News – Page 112 – Endpoints News

Ocaliva will continue to be available in the EU following European court's decision

9 months ago

Cigna offers discounted Stelara biosimilar, building on Humira move

9 months ago

Updated: Lykos CEO Amy Emerson resigns

9 months ago

The Endpoints 11 event is coming: Meet biotech’s hottest new startups

9 months ago

Novartis pays $15M upfront to license Voyager program; Boehringer advances geographic atrophy drug

9 months ago

MDLive veterans nab $7.5M Series A for virtual specialty care startup

9 months ago

Astellas to close facility in California; Takeda can make more of its ADHD drug

9 months ago

Exclusive: ZipBio launches using generative AI to make compact proteins

9 months ago

Lilly unveils more positive late-stage data for its once-weekly insulin

9 months ago

IN8bio pauses glioblastoma program, halves workforce as it prioritizes leukemia asset

9 months ago

BioMarin restructures following staff shakeup, slow Roctavian sales

9 months ago

Higher dose of Spinraza helped spinal muscular atrophy patients, Biogen says

9 months ago

Moderna’s mpox vaccine outperforms approved version in preclinical study

9 months ago

Court orders J&J to pay $1B following buyout of surgical robotics company

9 months ago

With $200M investment, Novartis builds out radioligand manufacturing at two sites

9 months ago

Vaxcyte aims to raise $1B after sharing pneumococcal vaccine data; More layoffs at Genentech

9 months ago

Little-known startup, backed by Foresite and Samsara, swings $60M China I&I deal

9 months ago

Transplant biotech eGenesis snags $191M after first use of gene-edited pig kidney

9 months ago

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

9 months ago

Roche unveils more mid-stage data for BTK inhibitor in relapsing multiple sclerosis

9 months ago

Cell therapy startup ArsenalBio raises $325M as it runs early solid tumor trials

9 months ago

Athira’s small molecule drug for Alzheimer’s fails in mid-stage study

9 months ago

BioAge files for IPO, riding momentum for weight loss drugs

9 months ago

Researchers seek answers as they spell out Phase 3 failure of Bayer’s next-gen anticoagulant

9 months ago

First page Previous page 109 110 111112113 114 115 Next page Last page